{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:39:12Z","timestamp":1792539552979,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23 MH128613"],"award-info":[{"award-number":["K23 MH128613"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2020143"],"award-info":[{"award-number":["2020143"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL152034"],"award-info":[{"award-number":["R01 HL152034"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpsychires.2025.05.065","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:43:39Z","timestamp":1748259819000},"page":"235-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparative cardiac safety of haloperidol vs. chlorpromazine among people receiving hemodialysis"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7181-105X","authenticated-orcid":false,"given":"Rebekah P.","family":"Nash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-6577","authenticated-orcid":false,"given":"Sherin","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley N.","family":"Gaynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4596-8536","authenticated-orcid":false,"given":"Jennifer E.","family":"Flythe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.065_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1681\/ASN.2018101032","article-title":"Comparative cardiac safety of selective serotonin reuptake inhibitors among individuals receiving maintenance hemodialysis","volume":"30","author":"Assimon","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.065_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.kint.2022.05.024","article-title":"Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure","volume":"102","author":"Assimon","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.065_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamacardio.2021.4234","article-title":"Analysis of respiratory fluoroquinolones and the risk of sudden cardiac death among patients receiving hemodialysis","volume":"7","author":"Assimon","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"27","key":"10.1016\/j.jpsychires.2025.05.065_bib4","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat. Med."},{"issue":"28","key":"10.1016\/j.jpsychires.2025.05.065_bib5","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.065_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jelectrocard.2016.07.016","article-title":"Sudden cardiac death in haemodialysis: clinical epidemiology and mechanisms","volume":"49","author":"Banerjee","year":"2016","journal-title":"J. Electrocardiol."},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.065_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"issue":"12","key":"10.1016\/j.jpsychires.2025.05.065_bib8","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/sj.ki.5000446","article-title":"Characteristics of sudden death in hemodialysis patients","volume":"69","author":"Bleyer","year":"2006","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.05.065_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hup.540","article-title":"Prolonged QTc intervals in medicated patients with schizophrenia","volume":"18","author":"Chong","year":"2003","journal-title":"Hum. Psychopharmacol."},{"issue":"446","key":"10.1016\/j.jpsychires.2025.05.065_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"7372","key":"10.1016\/j.jpsychires.2025.05.065_bib11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","article-title":"Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data","volume":"325","author":"Hennessy","year":"2002","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.065_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hernan","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.065_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1740774511420743","article-title":"Beyond the intention-to-treat in comparative effectiveness research","volume":"9","author":"Hernan","year":"2012","journal-title":"Clin. Trials"},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.065_bib14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hernan","year":"2008","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.065_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.psym.2014.07.004","article-title":"QTc prolongation and haloperidol: just how risky is this drug?","volume":"55","author":"Howland","year":"2014","journal-title":"Psychosomatics"},{"issue":"10202","key":"10.1016\/j.jpsychires.2025.05.065_bib16","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jpsychires.2025.05.065_bib17","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pds.3479","article-title":"Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study","volume":"22","author":"Iribarren","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.065_bib18","first-page":"1","article-title":"Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in Medicaid and dually-eligible medicaid-medicare beneficiaries of five states","volume":"10","author":"Leonard","year":"2013","journal-title":"J. Clin. Exp. Cardiolog. Suppl."},{"issue":"9896","key":"10.1016\/j.jpsychires.2025.05.065_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.065_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr. Epidemiol. Rep."},{"issue":"10","key":"10.1016\/j.jpsychires.2025.05.065_bib21","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/sj.ki.5000249","article-title":"Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging","volume":"69","author":"Mark","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jpsychires.2025.05.065_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.genhosppsych.2023.10.016","article-title":"Atypical antipsychotics and the risk of sudden cardiac death among individuals receiving maintenance hemodialysis","volume":"85","author":"Nash","year":"2023","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2025.05.065_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155445","article-title":"Electrocardiographic abnormalities and QTc interval in patients undergoing hemodialysis","volume":"11","author":"Nie","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.065_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pnpbp.2010.01.008","article-title":"QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia","volume":"34","author":"Ozeki","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2025.05.065_bib25","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/ndt\/gfh288","article-title":"The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey","volume":"19","author":"Paoletti","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.jpsychires.2025.05.065_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2215\/CJN.02820311","article-title":"Improving ascertainment of sudden cardiac death in patients with end stage renal disease","volume":"7","author":"Pun","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.jpsychires.2025.05.065_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081208","article-title":"Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe","volume":"8","author":"Raschi","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpsychires.2025.05.065_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9209","key":"10.1016\/j.jpsychires.2025.05.065_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.065_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcmg.2008.03.011","article-title":"Patterns of late gadolinium enhancement in chronic hemodialysis patients","volume":"1","author":"Schietinger","year":"2008","journal-title":"JACC Cardiovasc. Imag."},{"issue":"5","key":"10.1016\/j.jpsychires.2025.05.065_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"Sturmer","year":"2006","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"10.1016\/j.jpsychires.2025.05.065_bib32","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/joim.12197","article-title":"Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs","volume":"275","author":"Sturmer","year":"2014","journal-title":"J. Intern. Med."},{"issue":"8","key":"10.1016\/j.jpsychires.2025.05.065_bib33","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jpsychires.2025.05.065_bib36","series-title":"USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2022"},{"issue":"4","key":"10.1016\/j.jpsychires.2025.05.065_bib37","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jpsychires.2025.05.065_bib38","series-title":"QTdrugs Lists. AZCERT, Inc. , 1457 E. Desert Garden Dr","author":"Woosley","year":"2018"},{"issue":"2","key":"10.1016\/j.jpsychires.2025.05.065_bib39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hup.2458","article-title":"QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008\/2009","volume":"30","author":"Xiang","year":"2015","journal-title":"Hum. Psychopharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395625003656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:40:58Z","timestamp":1778647258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395625003656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"alternative-id":["S0022395625003656"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.065","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative cardiac safety of haloperidol vs. chlorpromazine among people receiving hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2025.05.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}